Tag:
Boniva
Latest Headlines
Latest Headlines
FDA review questions long-term use of bone-building drugs
The FDA is giving women a lot to chew on with a new analysis of long-term use of drugs for osteoporosis because they can, although rarely, have a debilitating effect.
Roche keeps up DTC on Boniva while others cut
Marketing osteoporosis drugs has grown more complicated since Merck's Fosamax went off patent a couple years ago. Now that there are low-cost alternatives to branded bisphosphonate treatments,
